122 related articles for article (PubMed ID: 6976995)
21. Modulation of TCR-mediated signaling pathway by thymic shared antigen-1 (TSA-1)/stem cell antigen-2 (Sca-2).
Saitoh S; Kosugi A; Noda S; Yamamoto N; Ogata M; Minami Y; Miyake K; Hamaoka T
J Immunol; 1995 Dec; 155(12):5574-81. PubMed ID: 7499840
[TBL] [Abstract][Full Text] [Related]
22. Antigen-dependent stimulation by bone marrow-derived mast cells of MHC class II-restricted T cell hybridoma.
Frandji P; Oskéritzian C; Cacaraci F; Lapeyre J; Peronet R; David B; Guillet JG; Mécheri S
J Immunol; 1993 Dec; 151(11):6318-28. PubMed ID: 8245470
[TBL] [Abstract][Full Text] [Related]
23. Antigen presentation by Ia+ B cell hybridomas to H-2-restricted T cell hybridomas.
Kappler J; White J; Wegmann D; Mustain E; Marrack P
Proc Natl Acad Sci U S A; 1982 Jun; 79(11):3604-7. PubMed ID: 6980413
[TBL] [Abstract][Full Text] [Related]
24. Characterization of lymphocyte-activating factor (LAF) produced by a macrophage cell line, P388D1. II. Biochemical characterization of LAF induced by activated T cells and LPS.
Mizel SB; Oppenheim JJ; Rosentreich DL
J Immunol; 1978 May; 120(5):1504-8. PubMed ID: 307016
[TBL] [Abstract][Full Text] [Related]
25. Cellular requirements for antigen processing by antigen-presenting cells: evidence for different pathways in forming the same antigenic determinants.
Kim KH; Solvay MJ; Thomas DW
Cell Immunol; 1985 Dec; 96(2):267-76. PubMed ID: 3879804
[TBL] [Abstract][Full Text] [Related]
26. Monoclonal anti-CD44 antibody acts in synergy with anti-CD2 but inhibits anti-CD3 or T cell receptor-mediated signaling in murine T cell hybridomas.
Guo YJ; Ma J; Wong JH; Lin SC; Chang HC; Bigby M; Sy MS
Cell Immunol; 1993 Nov; 152(1):186-99. PubMed ID: 7694807
[TBL] [Abstract][Full Text] [Related]
27. An anti-mouse macrophage monoclonal antibody reacting with T-derived leukaemic cells.
Martin A; Chevrinais AM; Bourel D; Fauchet R; Genetet B; Toujas L
Immunology; 1984 Jul; 52(3):539-46. PubMed ID: 6204931
[TBL] [Abstract][Full Text] [Related]
28. Identification of a macrophage antigen-processing event required for I-region-restricted antigen presentation to T lymphocytes.
Ziegler K; Unanue ER
J Immunol; 1981 Nov; 127(5):1869-75. PubMed ID: 6795263
[TBL] [Abstract][Full Text] [Related]
29. Sensitization of human lymphocytes in vitro: genetic restriction of secondary T cell responses is dictated by the HLA-DR phenotype of antigen-presenting cells.
Ford DM; Hamblin A; Burger DR
J Immunol; 1982 May; 128(5):2170-6. PubMed ID: 6977584
[TBL] [Abstract][Full Text] [Related]
30. Monoclonal c-myc transformed macrophage cell lines. I. Heterogeneity in ability to process and present antigen.
Trannoy E; Manser T; Cole MD; Daley MJ
J Immunol; 1993 Sep; 151(6):3042-56. PubMed ID: 8104218
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms of benzo(a)pyrene-induced modulation of antigen presentation.
Myers MJ; Schook LB; Bick PH
J Pharmacol Exp Ther; 1987 Aug; 242(2):399-404. PubMed ID: 3497259
[TBL] [Abstract][Full Text] [Related]
32. Reactivity of hybridomas derived from T cells activated in vivo during graft-versus-host disease.
Leibnitz RR; Lipsky PE; Thiele DL
J Immunol; 1994 Dec; 153(11):4959-68. PubMed ID: 7963559
[TBL] [Abstract][Full Text] [Related]
33. Altered cytokine production and accessory cell function after HIV-1 infection.
Yoo J; Chen H; Kraus T; Hirsch D; Polyak S; George I; Sperber K
J Immunol; 1996 Aug; 157(3):1313-20. PubMed ID: 8757640
[TBL] [Abstract][Full Text] [Related]
34. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
[TBL] [Abstract][Full Text] [Related]
35. Antigen presentation by normal B cells, B cell tumors, and macrophages: functional and biochemical comparison.
Chesnut RW; Colon SM; Grey HM
J Immunol; 1982 Apr; 128(4):1764-8. PubMed ID: 6977567
[No Abstract] [Full Text] [Related]
36. Aberrant antigen presentation by macrophages from tumor-bearing mice is involved in the down-regulation of their T cell responses.
Watson GA; Lopez DM
J Immunol; 1995 Sep; 155(6):3124-34. PubMed ID: 7673727
[TBL] [Abstract][Full Text] [Related]
37. Role of cannabinoid receptors in inhibiting macrophage costimulatory activity.
Chuchawankul S; Shima M; Buckley NE; Hartmann CB; McCoy KL
Int Immunopharmacol; 2004 Feb; 4(2):265-78. PubMed ID: 14996418
[TBL] [Abstract][Full Text] [Related]
38. Expression and function of mixed isotype MHC class II molecules in normal mice.
Spencer JS; Freed JH; Kubo RT
J Immunol; 1993 Dec; 151(12):6822-32. PubMed ID: 8258692
[TBL] [Abstract][Full Text] [Related]
39. Macrophage-chemotactic factor-producing T cell hybridomas reactive to phosphorylcholine in I-E-restricted manner.
Harita S; Sugimura K; Watanabe T
Eur J Immunol; 1984 Aug; 14(8):692-7. PubMed ID: 6205880
[TBL] [Abstract][Full Text] [Related]
40. Trinitrophenol reactive T-cell hybridomas recognize antigens that require antigen processing.
Ma J; Wang JH; Sy MS; Guo YJ; Hauser C; Bigby M
J Invest Dermatol; 1994 Jul; 103(1):42-8. PubMed ID: 8027580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
